Assessment of depressive symptoms in patients with COVID-19 during the second wave of epidemic in Myanmar: A cross-sectional single-center study
| Autor: | Aung Khant Min, Nay Aung, Kaung Myat Naing, Thet Wai Oo, Kyaw Myo Tun, Ye Minn Htun, Nay Hein Sint, Kyaw Thiha, Kyaw Hlaing, Pyae Sone Win, Aung Khyaw Aung |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Viral Diseases Cross-sectional study Economics medicine.medical_treatment Social Sciences Myanmar Geographical Locations 0302 clinical medicine Medical Conditions Prevalence Medicine and Health Sciences Medicine Psychology 030212 general & internal medicine Depression (differential diagnoses) Aged 80 and over Multidisciplinary Depression Center for Epidemiologic Studies Depression Scale Middle Aged Clinical Psychology Infectious Diseases Female Psychosocial Research Article Adult Asia Adolescent Social Psychology Science 03 medical and health sciences Statistical significance Mental Health and Psychiatry Psychoeducation Humans Epidemics Aged Psychological and Psychosocial Issues business.industry SARS-CoV-2 Mood Disorders Cognitive Psychology COVID-19 Biology and Life Sciences Covid 19 Odds ratio Confidence interval Health Care Cross-Sectional Studies People and Places Cognitive Science business 030217 neurology & neurosurgery Finance Demography Neuroscience |
| Zdroj: | PLoS ONE PLoS ONE, Vol 16, Iss 6, p e0252189 (2021) |
| ISSN: | 1932-6203 |
| Popis: | Background Coronavirus disease 2019 (COVID-19) pandemic has had a great impact on every aspect of society. All countries launched preventive measures such as quarantine, lockdown, and physical distancing to control the disease spread. These restrictions might effect on daily life and mental health. This study aimed to assess the prevalence and associated factors of depressive symptoms in patients with COVID-19 at the Treatment Center. Methods A cross-sectional telephone survey was carried out at Hmawbi COVID-19 Treatment Center, Myanmar from December 2020 to January 2021. A total of 142 patients with COVID-19 who met the criteria were invited to participate in the study. A pre-tested Center for Epidemiologic Studies Depression Scale (CES-D) was used as a tool for depressive symptoms assessment. Data were analyzed by using binary logistic regression to identify associated factors of depressive symptoms. Adjusted odds ratio (AOR) with a 95% confidence interval (CI) was computed to determine the level of significance with a p < 0.05. Results The prevalence of depressive symptoms in patients with COVID-19 was 38.7%, with the means (± standard deviation, SD) subscale of somatic symptom, negative effect, and anhedonia were 4.64 (±2.53), 2.51 (± 2.12), and 5.01 (± 3.26), respectively. The patients with 40 years and older (AOR: 2.99, 95% CI: 1.36–6.59), < 4 of household size (AOR: 3.45, 95% CI: 1.46–8.15), ≤ 400,000 kyats of monthly family income (AOR: 2.38, 95% CI: 1.02–5.54) and infection to family members (AOR: 4.18, 95% CI: 1.74–10.07) were significant associated factors of depressive symptoms. Conclusion The high prevalence of depressive symptoms, approximately 40%, was found in patients with COVID-19 in the Treatment Center. Establishments of psychosocial supports, providing psychoeducation, enhancing the social contact with family and friends, and using credible source of information related COVID-19 would be integral parts of mental health services in COVID-19 pandemic situation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|